US2010086966A1PendingUtilityA1
Feedback resistant acetohydroxy acid synthethase mutants
Est. expiryJun 26, 2023(expired)· nominal 20-yr term from priority
C12N 9/88C12P 13/08C12N 9/1022C12P 13/06
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides nucleotide sequences coding for acetohydroxy acid synthetase (AHAS) mutants, the mutated enzymes themselves and a process for the fermentative production of branched-chain amino acids using these enzymes in specific hosts in which genes which code for the modified acetohydroxy acid synthetase (AHAS) are expressed.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A process for preparing an enantiomer-enriched branched chain amino acid comprising:
fermenting a suitable medium with a cell encoding a polypeptide having acetohydroxy acid synthetase (AHAS) activity and encoding a polypeptide that does not contain the sequence Gly Ile Ile at the positions corresponding to residues 20-22 of SEQ ID NO: 2 comprising: (a) SEQ ID NO: 1, (b) SEQ ID NO: 3, or (c) a polynucleotide sequence that is at least 95% homologous to SEQ ID NO: 1 or 3; wherein said polynucleotide sequence does not encode a protein comprising the sequence Gly Ile Ile at the positions corresponding to residues 20-22 of SEQ ID NO: 2.
13 . The process of claim 12 , wherein said polynucleotide encodes the polypeptide of SEQ ID NO: 2 or SEQ ID NO: 4.
14 . The process of claim 12 , wherein said polynucleotide comprises SEQ ID NO: 1 or SEQ ID NO: 3.
15 . The process of claim 12 , wherein said polynucleotide encodes a polypeptide having Asp and Phe at the positions corresponding to residues 21 and 22 of SEQ ID NO: 2.
16 . The process of claim 12 , wherein said cornyneform bacteria have been transformed with a vector expressing said polypeptide.
17 . The process of claim 12 , wherein said cornyneform bacteria have been transformed with a vector expressing said polypeptide that is pECKA or pECKA/ilvBNC.
18 . The process of claim 12 , wherein the cell is corynebacterium.
19 . The process of claim 12 , wherein said cell is Corynebacterium.
20 . The process of claim 12 , wherein said cell is Corynebacterium glutamicum.
21 . The process of claim 12 , wherein said cell is Brevibacterium.
22 . The process of claim 12 , wherein said cell is selected from the group consisting of DSM15652, DSM 15561 and DSM15650.
23 . The process of claim 12 , wherein said branched chain amino acid is valine.
24 . The process of claim 12 , wherein said branched chain amino acid is leucine.
25 . The process of claim 12 , wherein said branched chain amino acid is isoleucine.
26 . A process for preparing an enantiomer-enriched branched chain amino acid comprising:
fermenting a suitable medium with a cell transformed with polynucleotide encoding a polypeptide having acetohydroxy acid synthetase (AHAS) activity, said polynucleotide comprising: (a) SEQ ID NO: 1, (b) SEQ ID NO: 3, or (c) a polynucleotide sequence that is at least 95% homologous to SEQ ID NO: 1 or SEQ ID NO: 3; wherein said polynucleotide is over-expressed by increasing its copy number, modifying its promoter, regulatory region or ribosome binding site, or by upstream incorporation of an expression cassette.
27 . The process of claim 26 , wherein said polynucleotide sequence encodes a protein comprising the sequence Gly Ile Ile at the positions corresponding to residues 20-22 of SEQ ID NO: 2Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.